Sectoral Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Sectoral Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,027	Closed	-$23K	–	89
2019 Q2	$23K	Sell	1,027 -2,482	-71%	-$120K	﹤0.01%	91
2019 Q1	$240K	Sell	3,509 -1,533	-30%	-$98.4K	0.03%	85
2018 Q4	$343K	Hold	5,042	–	–	0.05%	74
2018 Q3	$343K	Hold	5,042	–	–	0.04%	101
2018 Q2	$597K	Hold	5,042	–	–	0.07%	67
2018 Q1	$417K	Hold	5,042	–	–	0.05%	68
2017 Q4	$752K	Hold	5,042	–	–	0.09%	67
2017 Q3	$313K	Hold	5,042	–	–	0.04%	62
2017 Q2	$236K	Hold	5,042	–	–	0.03%	61
2017 Q1	$309K	Buy	+5,042	New	+$293K	0.04%	65
2016 Q4	–	Sell	-5,042	Closed	-$399K	–	65
2016 Q3	$399K	Hold	5,042	–	–	0.04%	56
2016 Q2	$1.36M	Sell	5,042 -23,385	-82%	-$4.46M	0.14%	58
2016 Q1	$7.66M	Buy	28,427 +5,663	+25%	+$1.81M	0.37%	51
2015 Q4	$14.4M	Buy	22,764 +1,195	+6%	+$809K	0.61%	43
2015 Q3	$17.3M	Buy	+21,569	New	+$24.3M	0.79%	32

Other funds holding SRRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Sectoral Asset Management's SRRA Position: Q3 2019 in Review

Sectoral Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2019, closing a stake of 1,027 shares — an estimated $23K sold.

Sectoral Asset Management first reported a position in SRRA in Q3 2015 and held it in 15 quarters. The position peaked at $17.3M in Q3 2015. 45 funds tracked by Wall St. Rank hold SRRA as of Q3 2019.

Sectoral Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Sectoral Asset Management sold 1,027 Sierra Oncology, Inc. Common Stock shares in Q3 2019, an estimated $23K.
Sectoral Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 15 quarters.
Sectoral Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $17.3M in Q3 2015.
45 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2019.

Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.